Canada · Health Canada Drug Product Database
NOVOLINSET GE 30/70 INJ SUS
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43555
- DIN
- 02024446
- Form
- Suspension
- Company as listed by source
- NOVO NORDISK A/S
- Source status
- Cancelled Post Market (2005-08-04)
- Source last updated
- 2025-03-22
Source-listed ingredients
- INSULIN INJECTION HUMAN BIOSYNTHETIC — 30 UNIT — per 1 ML
- INSULIN ISOPHANE HUMAN BIOSYNTHETIC — 70 UNIT — per 1 ML
These values do not establish equivalence or a dose recommendation.
Packages
- 3ml
Source and coverage
Open Health Canada Drug Product Database →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Canada records →